Jardiance (empagliflozin) is the newest member of the new class of diabetes medication called SGL2 Inhibitors. This class of medications works by eliminating excess blood glucose through the urine. Continue reading
We have discussed in our previous blogs as well as our topic on type 2 diabetes about the factors we consider when recommending treatment options for type 2 diabetes. Today by summarizing what we have previously discussed, we will provide you with the rationales behind what our endocrinologist recommends for the management of type 2 diabetes. Continue reading
One key aspect in the type 2 diabetes treatment is to avoid hypoglycemia and further weight gain. In our topic on type 2 diabetes, we classified treatments based on their risks of causing hypoglycemia and weight gain, and today we will elaborate on this topic.
Hypoglycemia simply means low blood sugar and it happens when our blood glucose level drops below the normal range. In diabetic patients, a blood glucose level below 3.9 mmol/L or 70 mg/dL is considered to be hypoglycemia. Continue reading
As we have discussed in our topic on type 2 diabetes, type 2 diabetes develops starting with our body developing resistance to the insulin our own pancreas is making. As a result, there is added pressure on the pancreas to produce more insulin to keep our blood sugar levels within normal range and over time our pancreas gets overworked and slowly loses its function. The main goal in type 2 diabetes treatment is obvious – keeping our blood glucose levels in check to prevent the development of nasty complications from having prolonged high blood sugar levels. But given the arsenal we have nowadays at our disposal, what we also need to consider is protecting and preserving our pancreatic functions while managing our blood sugars. Continue reading